Currently, out of the existing stock ratings of Chalres Zhu - 405 which are a Buy (77.14%), 115 which are a Hold (21.9%), 5 which are a Sell (0.95%)

Chalres Zhu

Work Performance Price Targets & Ratings Chart

Analyst Chalres Zhu works at GUGGENHEIM and is covering the Healthcare sector with 38 price targets and ratings displayed on 6 stocks.

Chalres Zhu's average stock forecast success ratio is 22.22% with an average time for price targets to be met of 44 days.

Most recent stock forecast was given on MGNX, MacroGenics at 23-Nov-2022.

Wall Street Analyst Chalres Zhu

Analyst best performing recommendations are on ZYME (ZYMEWORKS).
The best stock recommendation documented was for ZYME (ZYMEWORKS) at 11/20/2019. The price target of $48 was fulfilled within 58 days with a profit of $9.24 (23.84%) receiving and performance score of 4.11.

Average potential price target upside

RPTX Repare Therapeutics XNCR Xencor IDYA IDEAYA Biosciences MGNX MacroGenics MRUS Merus N.V ZYME Zymeworks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

17

$4.33 (34.18%)

16

3 days ago

1/5 (20%)

$9.71 (42.69%)

6

Buy

25

$12.33 (97.32%)

26

1 months 11 days ago

0/7 (0%)

$17.25 (109.50%)

Hold

14

$1.33 (10.50%)

15

7 months 1 days ago

1/6 (16.67%)

$8.83 (43.84%)

22

Buy

30

$17.33 (136.78%)

25

1 years 3 months 26 days ago

1/3 (33.33%)

$13.32 (95.55%)

104

Buy

44

$27.94 (173.97%)

46

1 years 10 months 18 days ago

0/2 (0%)

$14.68 (50.06%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Chalres Zhu?

On 2019

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart